Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the patient perspective and experience in drug development and review - FDA Press Releases

FDA issues update to Benefit-Risk Assessment plan as part of efforts to enhance the patient perspective and experience in drug development and review

from Food and Drug Administration--Press Releases https://ift.tt/2Grks7a
via IFTTT